Avalyn Pharma Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: AVLN
Avalyn Pharma Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker AVLN. It has reported private securities offerings to the US SEC, most recently $189 million sold in a notice filed in 2023.
Avalyn Pharma at a glance
What does Avalyn Pharma do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $189.2 million sold (2023).
Frequently asked questions about Avalyn Pharma
Where is Avalyn Pharma headquartered?
Avalyn Pharma Inc. is headquartered in Boston, Massachusetts, United States.
What does Avalyn Pharma do?
Avalyn Pharma Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Avalyn Pharma a public company?
Yes. Avalyn Pharma Inc. trades on Nasdaq under the ticker AVLN.
When was Avalyn Pharma founded?
The earliest incorporation on record for Avalyn Pharma Inc. is in 2011, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.